Rafal Kaminski, based in Italy, is currently a Chief Scientific Officer, Global R&D Head, Executive Committee Member at Angelini Pharma, bringing experience from previous roles at Angelini Pharma, Oncoarendi Therapeutics and Jagiellonian University Medical College. Rafal Kaminski holds a 2011 - 2014 Université Libre de Bruxelles. With a robust skill set that includes Clinical Trials, Translational Medicine, CRO, Cell Biology, Electrophysiology and more, Rafal Kaminski contributes valuable insights to the industry. Rafal Kaminski has 5 emails on RocketReach.